<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03857958</url>
  </required_header>
  <id_info>
    <org_study_id>1812-098-996</org_study_id>
    <nct_id>NCT03857958</nct_id>
  </id_info>
  <brief_title>Metal Versus Plastic Stent in Malignant Hilar Biliary Obstruction</brief_title>
  <official_title>Comparison of Metal Versus Plastic Side-by-side Stent Insertion in Malignant Hilar Biliary Obstruction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Taewoong Medical Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study was to compare the difference in the stent patency duration between
      side-by-side fully covered self-expanding metal stents (SEMS) and side-by-side plastic stents
      in patients with malignant hilar biliary obstruction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the case of distal common bile duct obstruction, the SEMS was reported to be clinically
      superior to the plastic stent in previous studies. However, there are few studies comparing
      the two methods in patients with malignant hilar biliary obstruction. In contrast to the
      distal common bile duct obstruction, the advantage of plastic stents over SEMSs exists, and
      plastic stents are used commonly in real clinical practice.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 15, 2019</start_date>
  <completion_date type="Anticipated">June 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of stent patency</measure>
    <time_frame>9 months after randomization.</time_frame>
    <description>The period from the insertion of the stent to the point at which stent revision is required.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">54</enrollment>
  <condition>Malignant Hepatobiliary Neoplasm</condition>
  <arm_group>
    <arm_group_label>FCSEMS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In patients with malignant hilar biliary obstruction, endoscopic drainage is performed for biliary drainage. Since intrahepatic bile ducts are separated, it is preferable to insert a stent into bilateral intrahepatic bile ducts for bile drainage if possible. In FCSEMS group, patients are inserted with Fully covered self-expandable metal stent (FCSEMS) bilaterally for malignant hilar biliary stricture via endoscopic retrograde cholangio-pancreatography.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Plastic stent</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In patients with malignant hilar biliary obstruction, endoscopic drainage is performed for biliary drainage. Since intrahepatic bile ducts are separated, it is preferable to insert a stent into bilateral intrahepatic bile ducts for bile drainage if possible. In plastic stent group, patients are inserted with plastic stents bilaterally for malignant hilar biliary stricture.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>endoscopic retrograde cholangio-pancreatography</intervention_name>
    <description>In patients who were identified to have malignant hilar biliary obstruction, bilateral stents insertion is attempted via ERCP. There will be two groups divided by stent material; FCSEMS and Plastic stent.</description>
    <arm_group_label>FCSEMS</arm_group_label>
    <arm_group_label>Plastic stent</arm_group_label>
    <other_name>Plastic stent</other_name>
    <other_name>FCSEMS</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Unresectable malignant hilar biliary stricture requiring biliary drainage through
             endoscopic procedure

        Exclusion Criteria:

          -  If endoscopy is not possible based on the judgement of the researcher

          -  Life expectancy less than 6 months

          -  Acute cholecystitis

          -  Previous history of percutaneous transhepatic biliary drainage

          -  Previous history of metal stent placement for malignant biliary stricture
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Seoul National University Hospital Seoul National University Hospital, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Min su You, MD</last_name>
    <phone>82-2-2072-2228</phone>
    <email>bass105@hanmail.net</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Woo Hyun Paik, MD, PhD</last_name>
    <phone>82-2-2072-2228</phone>
    <email>whpaik@snuh.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>03080</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Min su You, MD</last_name>
      <phone>82-2-2072-2228</phone>
      <email>bass105@hanmail.net</email>
    </contact>
    <contact_backup>
      <last_name>Woo Hyun Paik, MD, PhD</last_name>
      <phone>82-2-2072-2228</phone>
      <email>whpaik@snuh.org</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>February 27, 2019</study_first_submitted>
  <study_first_submitted_qc>February 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 28, 2019</study_first_posted>
  <last_update_submitted>April 3, 2019</last_update_submitted>
  <last_update_submitted_qc>April 3, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

